Optimi Health Corp.

As of June 30, 2026, Optimi Health Corp. carries a market capitalization of 42.37M, placing it among publicly traded companies globally. Its enterprise value stands at 34.44M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Optimi Health Corp.'s next confirmed earnings release is scheduled for February 2, 2027.

As of June 30, 2026, Optimi Health Corp. has 5.73M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 114.22, and the price-to-book ratio stands at 2.40.

These figures are as of June 30, 2026. The EV/Sales ratio of 196.06 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 34.44M versus a market cap of 42.37M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Optimi Health Corp. maintains a current ratio of 1.73, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 29.17, indicating elevated leverage, while an interest coverage ratio of -4.98 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Optimi Health Corp. posted a negative return on equity (ROE) of -54.35, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -34.50, reflecting losses generated across the asset base. Inventory turnover of 1.02 indicates how many times Optimi Health Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Optimi Health Corp.'s stock has declined approximately 59.39% over the past 52 weeks. The 50-day moving average sits at 6.30, while the 200-day moving average is 7.91.

Over the twelve months ended June 30, 2026, Optimi Health Corp. generated 175,671.00 in revenue and converted that into -6.90M in net income, yielding earnings per share of -2.54. EBITDA reached -4.93M, while operating income came in at -6.44M.

As of June 30, 2026, Optimi Health Corp. holds 13.07M in cash and equivalents against 5.14M in total debt, resulting in a net debt position of -8.09M. Total book value stands at 17.64M, with working capital of 5.88M providing operational flexibility.

Optimi Health Corp. produced -5.20M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Optimi Health Corp. posted a gross margin of -175.41, reflecting its pricing power and cost economics. The operating margin of -3,665.62 and net profit margin of -3,927.59 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -25.92: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -43.18, meaning Optimi Health Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Optimi Health Corp.'s most recent stock split took place on May 20, 2026 with a 30:1 split ratio.

As of June 30, 2026, Optimi Health Corp. has an Altman Z-Score of 0.85, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.